Covestor’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-11,184
Closed -$25K 2886
2023
Q2
$25K Buy
+11,184
New +$23.2K 0.02% 1045

Covestor's PRTK Position: Q3 2023 in Review

Covestor sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 11,184 shares — an estimated $25K sold.

Covestor first reported a position in PRTK in Q2 2023 and held it in 1 quarter. The position peaked at $25K in Q2 2023. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

  • Covestor reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Covestor sold 11,184 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $25K.
  • Covestor first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2023 and held it in 1 quarter.
  • Covestor's Paratek Pharmaceuticals, Inc. position peaked at $25K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Covestor's 13F filing for Q3 2023, filed 13 Nov 2023.